Literature DB >> 22454095

[Anemia and iron deficiency in the elderly. Prevalence, diagnostics and new therapeutic options].

G Röhrig1, W Doehner, R M Schaefer, R J Schulz.   

Abstract

The prevalence of anemia in geriatric patients is high. With some variation in different patient cohorts, prevalence of anemia can reach 40%. Anemia is not an age-related disease on its own, but is a symptom with multifactorial genesis and high risk potential. It directly influences mortality, morbidity, and the rate of hospitalization, particularly in older patients suffering from chronic heart failure or chronic kidney disease. The high prevalence of anemia in chronic kidney disease is explained by a combination of erythropoietin and iron deficiency. This review summarizes the recommendations of the iron symposium at the 2010 German Geriatric Society Meeting in Potsdam, Germany. It intends to provide current information on prevalence, diagnostic work-up, and therapeutic options for anemia in the rapidly growing group of elderly patients.

Entities:  

Mesh:

Year:  2012        PMID: 22454095     DOI: 10.1007/s00391-012-0320-8

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  38 in total

1.  Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.

Authors:  Nicola Tessitore; Domenico Girelli; Natascia Campostrini; Valeria Bedogna; Giovanni Pietro Solero; Annalisa Castagna; Edoardo Melilli; William Mantovani; Giovanna De Matteis; Oliviero Olivieri; Albino Poli; Antonio Lupo
Journal:  Nephrol Dial Transplant       Date:  2010-06-10       Impact factor: 5.992

2.  Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.

Authors:  Aidan P Bolger; Frederick R Bartlett; Helen S Penston; Justin O'Leary; Noel Pollock; Raffi Kaprielian; Callum M Chapman
Journal:  J Am Coll Cardiol       Date:  2006-08-28       Impact factor: 24.094

3.  The prevalence of anemia in chronic heart failure.

Authors:  Hildegard Tanner; Giorgio Moschovitis; Gabriela M Kuster; Roger Hullin; Dorothy Pfiiffner; Otto M Hess; Paul Mohacsi
Journal:  Int J Cardiol       Date:  2002-11       Impact factor: 4.164

4.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

5.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Authors:  D S Silverberg; D Wexler; M Blum; G Keren; D Sheps; E Leibovitch; D Brosh; S Laniado; D Schwartz; T Yachnin; I Shapira; D Gavish; R Baruch; B Koifman; C Kaplan; S Steinbruch; A Iaina
Journal:  J Am Coll Cardiol       Date:  2000-06       Impact factor: 24.094

6.  Monitoring of long-term peritoneal membrane function.

Authors:  S J Davies
Journal:  Perit Dial Int       Date:  2001 Mar-Apr       Impact factor: 1.756

7.  Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial.

Authors:  Rakesh Sharma; Darrel P Francis; Bertram Pitt; Philip A Poole-Wilson; Andrew J S Coats; Stefan D Anker
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

8.  Serum hepcidin-20 is elevated during the acute phase of myocardial infarction.

Authors:  Hiroshi Suzuki; Ken Toba; Kiminori Kato; Takuya Ozawa; Naohisa Tomosugi; Masato Higuchi; Taro Kusuyama; Yoshitaka Iso; Naohiko Kobayashi; Sin-ichiro Yokoyama; Noboru Fukuda; Hideki Saitoh; Kohei Akazawa; Yoshifusa Aizawa
Journal:  Tohoku J Exp Med       Date:  2009-06       Impact factor: 1.848

9.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

Authors:  Darlington O Okonko; Agnieszka Grzeslo; Tomasz Witkowski; Amit K J Mandal; Robert M Slater; Michael Roughton; Gabor Foldes; Thomas Thum; Jacek Majda; Waldemar Banasiak; Constantinos G Missouris; Philip A Poole-Wilson; Stefan D Anker; Piotr Ponikowski
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

Review 10.  Iron regulation and erythropoiesis.

Authors:  Elizabeta Nemeth
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

View more
  5 in total

1.  Diagnosis of iron deficiency anemia in the elderly: when to say "uncle".

Authors:  Richard Kozarek
Journal:  Dig Dis Sci       Date:  2013-02       Impact factor: 3.199

Review 2.  [Anemia in the aged - a geriatric syndrome? : Second position paper on anemia in the aged by the working group anemia of the German Geriatric Society].

Authors:  Gabriele Röhrig; Ines Gütgemann; Andreas Leischker; Gerald Kolb
Journal:  Z Gerontol Geriatr       Date:  2018-10-04       Impact factor: 1.281

3.  [Development and implementation of an integrated care pathway at the POLIKUM health centers using the example of anemia].

Authors:  M Bierbaum; M O Grad; H Wulff; S Kewenig; O Schöffski
Journal:  Internist (Berl)       Date:  2014-04       Impact factor: 0.743

4.  Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.

Authors:  Benjamin Lieske; Ingrid Becker; Ralf Joachim Schulz; Maria Cristina Polidori; Jan Kassubek; Gabriele Roehrig
Journal:  Z Gerontol Geriatr       Date:  2015-11-23       Impact factor: 1.281

Review 5.  [Iron, a "miralcle cure" for chronic cardiac insufficiency?]

Authors:  Katrin Singler
Journal:  Z Gerontol Geriatr       Date:  2017-12-14       Impact factor: 1.281

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.